Cargando…

The expression of long non-coding RNA HOTAIR in advanced hepatocellular carcinoma and its prognostic correlation with sunitinib therapy

INTRODUCTION: The study was designed to assess the expression of long non-coding RNA HOTAIR (lncRNA HOTAIR) in tissues and peripheral blood of patients with advanced hepatocellular carcinoma (HCC). In addition, we also investigated the prognostic correlation between the expression level of lncRNA HO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Chenyang, Yang, Yi, Guo, Li, Guan, Qiaobing, Ruan, Shuiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826866/ https://www.ncbi.nlm.nih.gov/pubmed/35154527 http://dx.doi.org/10.5114/aoms/100480

Ejemplares similares

Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma
por: Wu, Liming, et al.
Publicado: (2017)

Prognostic Value of Long Non-Coding RNA HOTAIR in Various Cancers
por: Deng, Qiwen, et al.
Publicado: (2014)

Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma
por: Yang, Liang, et al.
Publicado: (2019)

Progress of HOTAIR-microRNA in hepatocellular carcinoma
por: Wang, Bing-rong, et al.
Publicado: (2022)

Prognostic significance of long noncoding RNA HOTAIR in hepatocellular carcinoma: A protocol for systematic review and meta-analysis
por: Feng, Lei, et al.
Publicado: (2022)

HOTAIR: an oncogenic long non-coding RNA in different cancers
por: Hajjari, Mohammadreza, et al.
Publicado: (2015)

Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
por: Cantile, Monica, et al.
Publicado: (2020)

SCFAs promote intestinal double-negative T cells to regulate the inflammatory response mediated by NLRP3 inflammasome
por: Ruan, Shuiliang, et al.
Publicado: (2021)

Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma
por: Domagała-Haduch, Małgorzata, et al.
Publicado: (2016)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
por: Motzer, R J, et al.
Publicado: (2013)

HOTAIR: A Promising Long Non-coding RNA with Potential Role in Breast Invasive Carcinoma
por: Avazpour, Niloofar, et al.
Publicado: (2017)

Prognostic Value of Macrophage-Associated Long Non-Coding RNA Expression for Hepatocellular Carcinoma
por: Chen, Guan-Yu, et al.
Publicado: (2022)

Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma
por: Zhao, Yuan, et al.
Publicado: (2019)

Current Knowledge of Long Non-Coding RNA HOTAIR in Breast Cancer Progression and Its Application
por: Shi, Yubo, et al.
Publicado: (2021)

Structural and Functional Differences in the Long Non-Coding RNA Hotair in Mouse and Human
por: Schorderet, Patrick, et al.
Publicado: (2011)

Long non-coding RNA HOTAIR is associated with human cervical cancer progression
por: KIM, HEE JUNG, et al.
Publicado: (2014)

HOTAIR Long Non-coding RNA: Characterizing the Locus Features by the In Silico Approaches
por: Hajjari, Mohammadreza, et al.
Publicado: (2017)

The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma
por: Xavier-Magalhães, Ana, et al.
Publicado: (2018)

Expression of the long non-coding RNA HOTAIR as a prognostic factor in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
por: Troiano, Giuseppe, et al.
Publicado: (2017)

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
por: Cella, D, et al.
Publicado: (2012)

Long Non-Coding RNA HOTAIR Promotes Cell Migration and Invasion via Down-Regulation of RNA Binding Motif Protein 38 in Hepatocellular Carcinoma Cells
por: Ding, Chaofeng, et al.
Publicado: (2014)

Long Noncoding RNA HOTAIR Is a Prognostic Marker for Esophageal Squamous Cell Carcinoma Progression and Survival
por: Lv, Xiao-Bin, et al.
Publicado: (2013)

Enhanced Expression of Long Non-Coding RNA HOTAIR Is Associated with the Development of Gastric Cancer
por: Endo, Hiroyuki, et al.
Publicado: (2013)

Long non-coding RNA HOTAIR polymorphism and susceptibility to cancer: an updated meta-analysis
por: Li, Juan, et al.
Publicado: (2018)

Association Between SNPs of Long Non-coding RNA HOTAIR and Risk of Different Cancers
por: Hajjari, Mohammadreza, et al.
Publicado: (2019)

The emerging role of the long non-coding RNA HOTAIR in breast cancer development and treatment
por: Mozdarani, Hossein, et al.
Publicado: (2020)

Down-regulation of long non-coding RNA HOTAIR sensitizes breast cancer to trastuzumab
por: Chen, Tianwen, et al.
Publicado: (2019)

Long Non-Coding RNA HOTAIR Expression and Clinical Significance in Patients with Gestational Diabetes
por: Su, Ruifen, et al.
Publicado: (2021)

Long Non-Coding RNAs H19 and HOTAIR Implicated in Intervertebral Disc Degeneration
por: Wang, Zhun, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of the long non-coding RNA HOTAIR high expression in head and neck squamous cell carcinoma: a systematic review and meta-analysis
por: Yang, Gang, et al.
Publicado: (2022)

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
por: Bamias, A, et al.
Publicado: (2013)

Impact of Long Non-Coding RNA HOTAIR Genetic Variants on the Susceptibility and Clinicopathologic Characteristics of Patients with Urothelial Cell Carcinoma
por: Tung, Min-Che, et al.
Publicado: (2019)

The Role and Mechanism of Long Non-Coding RNA HOTAIR in the Oncogenesis, Diagnosis, and Treatment of Head and Neck Squamous Cell Carcinoma
por: Xiang, Yuandi, et al.
Publicado: (2023)

Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer
por: Milevskiy, Michael J.G., et al.
Publicado: (2016)

The prognostic value of HOTAIR for predicting long-term prognosis of patients with gastrointestinal cancers
por: Zhang, Yi, et al.
Publicado: (2018)

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
por: Rini, Brian I, et al.
Publicado: (2022)

Sunitinib re-challenge in advanced renal-cell carcinoma
por: Porta, C, et al.
Publicado: (2014)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
por: Hutson, T E, et al.
Publicado: (2014)

Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
por: Gilabert, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a6qlftesa66mrd1eb262h1ttkt